Clown-Free Zone... sorry, no clowns allowed Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pater tenebrarum who wrote (103032)	5/17/2001 4:20:57 PM
From: patron_anejo_por_favor	Read Replies (1) of 436258

Pharmacia to "smell the glove" tomorrow: cbs.marketwatch.com NEW YORK (CBS.MW) -- Two studies of a drug combination used to treat colon cancer have been suspended after researchers discovered that the regimen was causing an unexpectedly high death rate. Because of the urgency of the situation, researchers with the National Cancer Institute reported their findings early in a letter in this week's edition of the New England Journal of Medicine, published on Thursday. Publication was scheduled for June 21. The drugs given to patients in the studies are irinotecan, marketed by Pharmacia (PHA: news, msgs, alerts) as Camptosar, and leucovorin combined with chemotherapy drugs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next